- Home
- CLDT vs SVRA Comparison
CLDT vs SVRA Comparison
Compare CLDT & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- SVRA
- Stock Information
- Founded
- CLDT 2009
- SVRA N/A
- Country
- CLDT United States
- SVRA United States
- Employees
- CLDT N/A
- SVRA N/A
- Industry
- CLDT Real Estate Investment Trusts
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- SVRA Health Care
- Exchange
- CLDT Nasdaq
- SVRA Nasdaq
- Market Cap
- CLDT 429.4M
- SVRA 458.2M
- IPO Year
- CLDT 2010
- SVRA N/A
- Fundamental
- Price
- CLDT $8.11
- SVRA $2.69
- Analyst Decision
- CLDT Strong Buy
- SVRA Buy
- Analyst Count
- CLDT 2
- SVRA 7
- Target Price
- CLDT $12.00
- SVRA $9.86
- AVG Volume (30 Days)
- CLDT 238.5K
- SVRA 633.7K
- Earning Date
- CLDT 02-26-2025
- SVRA 03-06-2025
- Dividend Yield
- CLDT 3.45%
- SVRA N/A
- EPS Growth
- CLDT N/A
- SVRA N/A
- EPS
- CLDT N/A
- SVRA N/A
- Revenue
- CLDT $313,268,000.00
- SVRA N/A
- Revenue This Year
- CLDT N/A
- SVRA N/A
- Revenue Next Year
- CLDT $3.83
- SVRA N/A
- P/E Ratio
- CLDT N/A
- SVRA N/A
- Revenue Growth
- CLDT 1.77
- SVRA N/A
- 52 Week Low
- CLDT $7.60
- SVRA $2.59
- 52 Week High
- CLDT $10.65
- SVRA $5.70
- Technical
- Relative Strength Index (RSI)
- CLDT 30.29
- SVRA 40.81
- Support Level
- CLDT $8.33
- SVRA $2.65
- Resistance Level
- CLDT $8.58
- SVRA $2.91
- Average True Range (ATR)
- CLDT 0.18
- SVRA 0.11
- MACD
- CLDT -0.04
- SVRA 0.01
- Stochastic Oscillator
- CLDT 1.85
- SVRA 23.08
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.